Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank86
3Y CAGR+49.8%
5Y CAGR+90.4%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+49.8%/yr
vs +102.0%/yr prior
5Y CAGR
+90.4%/yr
Recent deceleration
Acceleration
-52.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
25x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$22.21M-25.1%
2024$29.66M+37.1%
2023$21.63M+227.1%
2022$6.61M+1286.0%
2021$477000.00-46.3%
2020$888000.00+43.2%
2019$620000.00+56.2%
2018$397000.00-